investors
With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.
We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.
- Mikael Haag
-
CFO AND HEAD OF INVESTOR RELATIONS
- ir@sedanamedical.com
The Share
Press Releases
2026
2026-10-22 07:00
FDA review under way and sales growth returns Third quarter 2026 January-September 2026 CEO comments FDA review under way and sales growth returns The...
2026-10-15 07:00
Sedana Medical AB (publ) plans to present its interim report for the third quarter of 2026 on Thursday, October 22, 2026, at 13:30 CET. According to the...
2026-10-14 17:30
According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the Annual General...
Financial Reports
Financial Calendar
Latest Presentation
No presentations found.
